1 / 1

GISSI-HF: n-3 PUFA Study

GISSI-HF: n-3 PUFA Study. No difference between the two arms for primary endpoint (death), but significant difference noted on multivariate analysis ( HR 0.91, 95.5% CI 0.83-1.0; p = 0.041)

arty
Download Presentation

GISSI-HF: n-3 PUFA Study

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. GISSI-HF: n-3 PUFA Study No difference between the two arms for primary endpoint (death), but significant difference noted on multivariate analysis (HR 0.91, 95.5% CI 0.83-1.0; p = 0.041) No difference in the incidence of first admission for heart failure, but fewer admissions for arrhythmia related issues (p = 0.013) (p = 0.12) (p = 0.013) n-3 PUFA (n = 3,494) Placebo (n = 3,481) Trial design: Patients with symptomatic CHF were randomized to 1 g n-3 PUFA daily or placebo, in addition to optimal medical treatment. Clinical outcomes were compared at 12 months. Results 29.1 30 20 27.3 15 20 % % Conclusions 10 • No significant difference in mortality in the n-3 PUFA arm, compared with placebo in patients with symptomatic heart failure, on optimal treatment • However, multivariate analysis showed n-3 PUFA was associated with small reduction in mortality (absolute RR 1.8%) compared with placebo • Exact mechanism is unclear, although reduction in readmission for arrhythmias was noted 10 4.0 5 3.0 0 0 Arrhythmia related hospitalization Mortality GISSI-HF Investigators. Lancet 2008;Aug 31:[Epub]

More Related